Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
주식 순위 #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
주가
$18.20
마지막 동기화: 2025-05-09
시가총액
$220.35M
변동 (1일)
-5.34%
변동 (1년)
0.00%
국가
JP
거래 I'rom Group Co., Ltd. (2372)

카테고리

I'rom Group Co., Ltd. (2372)의 수익
Dec 2024 기준 수익 TTM: $9.98M
I'rom Group Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $9.98M입니다. 2023년에 회사는 $25.17M의 수익을 올렸으며 이는 2022년의 수익 $21.24M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
I'rom Group Co., Ltd.의 수익 기록 (2005 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
유사 기업 또는 경쟁사의 수익